109 related articles for article (PubMed ID: 12583508)
1. Telomerase inhibitors in anticancer therapy: gossypol as a potential telomerase inhibitor.
Mego M
Bratisl Lek Listy; 2002; 103(10):378-81. PubMed ID: 12583508
[TBL] [Abstract][Full Text] [Related]
2. Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT.
Moon DO; Kim MO; Choi YH; Lee HG; Kim ND; Kim GY
FEBS Lett; 2008 Oct; 582(23-24):3367-73. PubMed ID: 18775705
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
[TBL] [Abstract][Full Text] [Related]
4. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
Saraswati AP; Relitti N; Brindisi M; Gemma S; Zisterer D; Butini S; Campiani G
Drug Discov Today; 2019 Jul; 24(7):1370-1388. PubMed ID: 31136800
[TBL] [Abstract][Full Text] [Related]
5. Ageing and cancer: the telomere and telomerase connection.
Shay JW; Wright WE
Novartis Found Symp; 2001; 235():116-25; discussion 125-9, 146-9. PubMed ID: 11280022
[TBL] [Abstract][Full Text] [Related]
6. Telomerase: biology and phase I trials.
Kelland LR
Lancet Oncol; 2001 Feb; 2(2):95-102. PubMed ID: 11905801
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
9. Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity.
Sahin F; Avci CB; Gunduz C; Sezgin C; Simsir IY; Saydam G
Hematology; 2010 Jun; 15(3):144-50. PubMed ID: 20557672
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Colangelo D; Osella D
Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
[TBL] [Abstract][Full Text] [Related]
11. The 'other' telomerase inhibitors: non-G-quadruplex interactive agent, non-antisense, non-reverse transcriptase telomerase inhibitors.
Beltz LA
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):589-603. PubMed ID: 12678726
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase activity by cisplatin in human testicular cancer cells.
Burger AM; Double JA; Newell DR
Eur J Cancer; 1997 Apr; 33(4):638-44. PubMed ID: 9274448
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and cancer.
Testorelli C
J Exp Clin Cancer Res; 2003 Jun; 22(2):165-9. PubMed ID: 12866565
[TBL] [Abstract][Full Text] [Related]
15. [The direct effect of anticancer agents on the telomerase activity in human cancer cell lines].
Akiyama M; Yamada H
Nihon Rinsho; 1998 May; 56(5):1165-70. PubMed ID: 9613115
[TBL] [Abstract][Full Text] [Related]
16. Oligonucleotide N3' --> P5' thio-phosphoramidate telomerase template antagonists as potential anticancer agents.
Gryaznov S; Asai A; Oshima Y; Yamamoto Y; Pongracz K; Pruzan R; Wunder E; Piatyszek M; Li S; Chin A; Harley C; Akinaga S; Yamashita Y
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):577-81. PubMed ID: 14565232
[TBL] [Abstract][Full Text] [Related]
17. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
18. Hallmarks of telomeres in ageing research.
Shay JW; Wright WE
J Pathol; 2007 Jan; 211(2):114-23. PubMed ID: 17200948
[TBL] [Abstract][Full Text] [Related]
19. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
20. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
